IL-6 is suggested to modulate the local tumor microenvironment and systemic immune responses contributing to the immunosuppressive environment and allow cancer cells to acquire an advanced malignant phenotype in cancer patients [32,33]. This evidence concerns the gene IL6 and neoplasm.